Background: Insulin (1) and glutamic acid decarboxylase (GAD) (2) are both autoantigens in insulin-depen-
INTRODUCTION
The selective destruction of ,3 cells in the pancreatic islets leading to insulin deficiency and insulin-dependent diabetes mellitus (IDDM) is considered to be an autoimmune process mediated primarily by autoreactive T cells (reviewed in Ref. 3) . Thus, in rodent models of IDDM, the "insulitis" lesion of the islets comprises a mixed mononuclear cell infiltrate, the disease can be transferred by T cells to naive animals, and disease expression is prevented by a variety of anti-T cell agents (reviewed in Ref. 3) . In humans with recently diagnosed IDDM, examination of pancreas tissue obtained at postmortem (4) (5) (6) or by needle biopsy (7, 8 ) reveals a similar though less florid insulitis lesion. Without immunosuppression, insulitis recurs in pancreas isografts between HLA-identical twins (9) . The effect of the immunosuppressive agents, cyclosporine and azathioprine, to induce and/or prolong remissions after diagnosis of IDDM (reviewed in Ref. (11) . Certainly, insulin is the only known (3 cell-specific autoantigen in IDDM, and mounting evidence suggests its involvement in human diabetes. Autoantibodies to its parent, proinsulin, have also been found in IDDM (12) . Prospective studies of the offspring of IDDM families, by our laboratory and elsewhere (13) , suggest that insulin autoantibodies (IAA) are the earliest detectable marker of (3 cell autoimmunity.
Several studies have also demonstrated specific T cell reactivity to islet antigens. Whole islets stimulate the proliferation of T cells from subjects at-risk for or with clinical IDDM significantly more than autoimmune or HLA-matched healthy control subjects (14, 15) . GAD peptides or recombinant GAD also stimulate T cells in these IDDM groups (16) (17) (18) . However, attempts to demonstrate T cell reactivity to insulin have been largely unsuccessful in humans (15) , although insulin is a target for islet-reactive T cells in mice (19) . Similar studies with proinsulin have not been published.
We have observed that a short region (13 amino acids) in the sequence of proinsulin bears marked similarity (six identical, three conserved residues) to a sequence from GAD (Fig. 1) . This similarity is found in both GAD isoforms (GAD65 and GAD67), as well as in the mouse GAD enzymes and proinsulins. It is notable that this region lies within a portion of human GAD65 (amino acids 473-543) shown to be immunodominant for T cells of IDDM patients (18) . As well, it is largely included in one of the two mouse GAD65 peptides (amino acids 509-528) that are the earliest to be recognized by T cells in the NOD model of IDDM (20) . Finally, the proinsulin sequence spans the cleavage site (Arg 32-Glu 33) of the PC 1/3 convertase (21) , which separates the C peptide from the insulin B chain. This region is therefore absent from the mature insulin molecule and would not have been previously tested in assays based on insulin or its peptide fragments. The present study was designed to address whether this region of similarity might be a focus of T cell autoreactivity in IDDM, thereby providing a molecular basis for the observation of shared autoimmunity to GAD and (pro)insulin.
MATERIALS AND METHODS

Subjects
Subjects at-risk for IDDM were from the Melbourne Prediabetes Family Study. Each was entered on the basis of having at least one first degree relative with IDDM, and islet cell antibody (ICA) .20 JDF units and/or IAA 2 100 nU/ml ( Table 1 ). All had normal fasting blood glucose and glycated hemoglobin, and have had repeat antibody and metabolic tests at six monthly intervals. Control subjects were HLA-DR matched, asymptomatic, and without history of IDDM.
All subjects gave informed, signed consent, and the study was l>tAA, Insulin autoantibody titres (nU insulin bound/ml serum). IAA were assayed by a radiobinding method which has been internationally standardized. The upper limit for normal control sera is 40 nU insulin bound/ml serum. GAD antibodies were assayed by immunoprecipitation of GAD enzymatic activity from piglet brain extract (22) . The mean plus 3 SD of 72 healthy subjects, 460nU/ml, was used to define the normal range. FIRST T cell proliferative responses to the similar 1 3-mer peptides from proinsulin and GAD were compared for 10 pairs of HLA-DR-matched atrisk and control subjects. HLA-DR matching was thought to be important not only because of the specificity of peptide binding to MHC class II alleles but also because of the known association between MHC class II and IDDM. Therefore, T cell responses would reflect IDDM rather than MHC specificity. Responses to the highest concentration of either peptide were significantly (proinsulin: p < 0.008; GAD: p < 0.018-Wilcoxon one-tailed paired analysis) greater among at-risk than control subjects (Table 2 ). Reactivity to the proinsulin sequence was confined almost entirely to at-risk subjects, whereas some controls also responded to the GAD peptide ( Table 2 , Fig. 2 ). Both groups responded similarly to tetanus, and no subject reacted to the unrelated control peptide.
For six of these pairs (#1, 2, 3, 5, 6, and 7), the assay was performed on a separate occasion, but using twice as many cells (4 X 105 per well).
Exhaustion of the media resulted in unreliable results in three cases. In two of the other three (#5 and 6), the results were consistent with those sponse to the antigens: proinsulin peptide 10 ,tg/ml, GAD peptide 10 ,ug/ml, control peptide 10 jig/ml, and tetanus toxoid 1.8 LfU/ml Error bars indicate mean and 95% confidence interval.
tabulated here, while in the third (#3) the at-risk subject displayed greater reactivity to both antigens at the higher cell number. These results indicate that there is probable reproducibility between tests, although a larger number of subjects using similar cell numbers would be required to confirm this. Similarly, a larger number of subjects is necessary to determine whether there is an association between the observed T cell reactivity and clinical parameters. Long-term follow-up will be required to determine whether this reactivity has predictive value for development of IDDM.
DISCUSSION
This is the first published demonstration of T cell reactivity to a proinsulin-specific peptide. The absence of this sequence from the mature insulin molecule, due to processing by the PC 1/3 convertase enzyme, may account for the previously encountered difficulty in finding insulin-reactive T cells in at-risk or recently diagnosed subjects (15) . A number of papers not only have documented elevated proinsulin levels in early-onset IDDM and at-risk subjects (23) (24) (25) (26) (27) , but also have reported proinsulin autoantibodies (12, 28, 29 (18, 17) , which includes the peptide we have studied here, although they neither examined it specifically nor employed HLA-matched controls. This region also appears to be a focus of humoral immunity to GAD in IDDM (37, 38) . The phenomenon of B and T cell epitope concordance has been noted in several other instances, and may be indicative of a role for antibody in amplifying or focusing the immune response. Examples include epitopes from the inner lipoyl domain of PDC-E2 in primary biliary cirrhosis (39) and from poliovirus (40) . It is interesting to speculate on the potential significance of this overlap at a molecular level of cellular and humoral responses. While initial breaking of T cell tolerance, due to aberrant processing and presentation of self antigens or mimicry with foreign pathogen, might seem a likely route to autoimmunity, the alternative direction of spread from activated B to T cell has also been described (41) . In either case, careful analysis of linear sequence similarity between known autoantigens may provide clues to the genesis of T cell immunity underlying disease.
That the proinsulin epitope spans the natural convertase cleavage site may be significant in the pathogenesis of IDDM. Perhaps an early event in this pathogenesis involves abnormal processing of proinsulin, resulting in an unusual intermediate or an unusual amount of an intermediate. In individuals with a permissive MHC, this intermediate might subsequently be processed and presented by APCs resident in the islets to T cells not tolerant of this normally "cryptic" epitope. An alternative scenario is direct presentation by the ,B cell itself. Class II MHC and accessory molecules like ICAM-I can be induced in human islet cells exposed to immuno-inflammatory cytokines (42, 43) , but it is arguable whether the ,B cell thereby acquires the functionality of an APC. There is some evidence that autoimmunity to GAD precedes that to insulin in NOD mice (20, 44) . We and others have found that normal individuals can have T cell reactivity to GAD (cf. proinsulin). One could speculate that while many individuals have T cells reactive to GAD, these are initially nonpathogenic. Subsequent expansion of some of these T cell clones that are cross-reactive with proinsulin may produce activated clones with increased pathogenicity (e.g., due to increased adhesion molecules, costimulator molecules, cytokine production, etc.) and might provide the trigger for insulitis. This hypothesis predicts that tolerization regimens with either GAD or proinsulin should prevent disease onset.
